MyAverix Finance
NS · Pharmaceuticals
Alkem Laboratories Ltd (ALKEM)
Pharmaceuticals & Biotechnology
Alkem Laboratories Ltd (ALKEM) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $645.65B, P/E ratio is 28.29, net margin is 21.4%, dividend yield is 0.80%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ALKEM
Alkem Laboratories Ltd (ALKEM) — FAQ
What is Alkem Laboratories Ltd's market cap?
Alkem Laboratories Ltd (ALKEM) has a reported market cap of $645.65B (data as of 2026-07-10).
What is ALKEM's P/E ratio?
The price-to-earnings (P/E) ratio for Alkem Laboratories Ltd (ALKEM) is 28.29 (data as of 2026-07-10).
Does Alkem Laboratories Ltd pay a dividend?
Alkem Laboratories Ltd (ALKEM) shows a reported dividend yield of 0.80%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Alkem Laboratories Ltd in?
Alkem Laboratories Ltd (ALKEM) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is ALKEM listed on?
ALKEM is listed on NS.
What is Alkem Laboratories Ltd's net margin?
Alkem Laboratories Ltd (ALKEM) reports a net margin of 21.4% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.